ArticleCancer science2022

Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma.

Dianxing Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.